{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:02:23Z","timestamp":1791223343272,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1136\/ard.2007.069799","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T01:59:48Z","timestamp":1177466388000},"page":"1610-1615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy"],"prefix":"10.1016","volume":"66","author":[{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Breban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Weldingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Emilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.069799_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.069799_bib2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069799_bib3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.11134","article-title":"Tuberculosis in the cytokine era: what rheumatologists need to know","volume":"48","author":"Hamilton","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1136\/ard.2007.069799_bib4","doi-asserted-by":"crossref","first-page":"ii62","DOI":"10.1136\/ard.61.suppl_2.ii62","article-title":"Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents","volume":"61","author":"Furst","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib5","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.069799_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/rheumatology\/keh567","article-title":"TNF-blocking agents and tuberculosis: new drugs illuminate an old topic","volume":"44","author":"Keane","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.069799_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.2301002","article-title":"Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?","volume":"167","author":"Jasmer","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1297-319X(02)00387-1","article-title":"Recommendations about the prevention and management of tuberculosis in patients taking infliximab","volume":"69","author":"Salmon","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1136\/ard.2007.069799_bib10","unstructured":"http:\/\/agmed.sante.gouv.fr\/htm\/10\/tnf\/reco.pdf (accessed April 2007)."},{"key":"10.1136\/ard.2007.069799_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1136\/ard.2007.069799_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/ard.2007.069799_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2002.004598","article-title":"High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors","volume":"62","author":"Vanhoof","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1136\/ard.2007.069799_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2006.00941.x","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"11","author":"Yew","year":"2006","journal-title":"Respirology"},{"key":"10.1136\/ard.2007.069799_bib16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"Ponce de Leon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1136\/ard.2007.069799_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/ajrccm.163.4.ed0201c","article-title":"Diagnosing latent tuberculosis infection: the 100-year upgrade","volume":"163","author":"Barnes","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"10.1136\/ard.2007.069799_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1164\/ajrccm.173.1.130","article-title":"Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis","volume":"173","author":"Piana","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069799_bib23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069799_bib24","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"Hamdi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2007.069799_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.200402-232OC","article-title":"Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts","volume":"170","author":"Brock","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7326\/0003-4819-140-9-200405040-00010","article-title":"Early diagnosis of subclinical multidrug-resistant tuberculosis","volume":"140","author":"Richeldi","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2007.069799_bib27","article-title":"Quantiferon TB gold test: The new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00365540410015222","article-title":"Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test","volume":"36","author":"Ravn","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1136\/ard.2007.069799_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.069799_bib30","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl","key":"10.1136\/ard.2007.069799_bib31","first-page":"S329","article-title":"Screening for Latent Tuberculosis Infection (LTBI) prior to Anti-tnf therapy: evaluation of T cell-based interferon-release assays","volume":"9","author":"Martin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069799_bib32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.200505-748OC","article-title":"Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection","volume":"172","author":"Shams","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069799_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","article-title":"Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak","volume":"361","author":"Ewer","year":"2003","journal-title":"Lancet"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672434587X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672434587X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.069799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:29:20Z","timestamp":1736123360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672434587X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S000349672434587X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.069799","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.069799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 2007 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}